SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549


                                 --------------

                                  SCHEDULE 13D
                                 (Rule 13d-101)


                 INFORMATION TO BE INCLUDED IN STATEMENTS FILED
                          PURSUANT TO RULE 13d-1(a) AND
               AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
                              (AMENDMENT NO. 2 ) 1
                                            ---


                           Senesco Technologies, Inc.
                           --------------------------
                                (Name of Issuer)


                           Common Stock, $.01 par value
                           ----------------------------
                         (Title of Class of Securities)


                                   817208 40 8
                                   -----------
                                 (CUSIP Number)


Joel Brooks,  303 George Street, Suite  420,  New Brunswick,  New Jersey   08901
--------------------------------------------------------------------------------
                                 (732-296-8400)
                                 --------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
                                Communications)


                                December 31, 2001
                                -----------------
             (Date of Event Which Requires Filing of this Statement)


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  that is the subject of this  Schedule  13D, and is filing this
schedule  because of Rule  13d-1(e),  13d-1(f) or 13d-1(g),  check the following
box. |_|

Note.  Schedules  filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits.

See Rule 13d-7(b) for other parties to whom copies are to be sent.

                         (Continued on following pages)
                               (Page 1 of 6 Pages)


----------------------
1       The remainder of this  cover page shall be  filled  out for a  reporting
person's  initial  filing on this  form with  respect  to the  subject  class of
securities,  and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 or  otherwise  subject to the  liabilities  of that  section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).



-------------------------------             ---------------------------------
    CUSIP No. 817208 40 8          13D                Page 2 of 6 Pages
             ------------                                 ---  ---
-------------------------------             ---------------------------------

-----------------------------------------------------------------------------
  1    NAMES OF REPORTING PERSONS
       I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

       The Umbrella Project, L.L.C.
       -------------------------------      -----------
-----------------------------------------------------------------------------
  2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*            (a)|_|
                                                                    (b)|_|
-----------------------------------------------------------------------------
  3    SEC USE ONLY

-----------------------------------------------------------------------------
  4    SOURCE OF FUNDS *       WC, PF

-----------------------------------------------------------------------------
  5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
       ITEM 2(d) or 2 (e)                                              |_|

-----------------------------------------------------------------------------
  6    CITIZENSHIP OR PLACE OF ORGANIZATION

             New Jersey, U.S.A.
             ------------------
-----------------------------------------------------------------------------
   NUMBER OF      7  SOLE VOTING POWER              771,089 (See Item 5)
                                                  ---------
     SHARES      ------------------------------------------------------------

  BENEFICIALLY    8  SHARED VOTING POWER            N/A

    OWNED BY     ------------------------------------------------------------

      EACH        9  SOLE DISPOSITIVE POWER         771,089 (See Item 5)
                                                  ---------
   REPORTING     ------------------------------------------------------------

  PERSON WITH    10  SHARED DISPOSITIVE POWER       N/A

-----------------------------------------------------------------------------
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

            771,089 ( See Item 5)
            -------
-----------------------------------------------------------------------------
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
       CERTAIN SHARES*                                                |_|

-----------------------------------------------------------------------------
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11              7.72%
                                                                  -----------
-----------------------------------------------------------------------------
  14   TYPE OF REPORTING PERSON*                                      PN

-----------------------------------------------------------------------------

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!



 ITEM 1.  SECURITY AND ISSUER.

          The title of the class of equity  securities  to which this  statement
          relates is common  stock,  $.01 par value  (the  "Common  Stock"),  of
          Senesco  Technologies,  Inc., a Delaware  corporation (the "Company").
          The address of the principal  executive  offices of the Company is 303
          George Street, Suite 420, New Brunswick, New Jersey 08901.

 ITEM 2.  IDENTITY AND BACKGROUND.

          This Statement on Schedule 13D is being filed by The Umbrella Project,
          L.L.C.,  a New Jersey  limited  liability  company  ("Umbrella").  The
          address of Umbrella's principal place of business and principal office
          is 95  Old  Dutch  Road,  Far  Hills,  New  Jersey  07931.  Umbrella's
          principal  business is a holding company which invests in a variety of
          business  entities  conducting  various  activities.  Umbrella's  sole
          member is Phillip O. Escaravage. Mr. Escaravage is a citizen of Canada
          but a resident alien of the United States.

          During the last five years,  neither  Umbrella nor Mr.  Escaravage has
          been convicted in a criminal proceeding  (excluding traffic violations
          or similar  misdemeanors),  and Umbrella or Mr.  Escaravage  was not a
          party to a civil  proceeding of a judicial or  administrative  body of
          competent  jurisdiction  as a result of which  proceeding it was or is
          subject  to  a  judgment,  decree  or  final  order  enjoining  future
          violations  of, or  prohibiting  or mandating  activities  subject to,
          federal or state securities laws or finding any violation with respect
          to such laws.

 ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

          On  October  9,  1998,   Senesco,   Inc.,  a  New  Jersey  corporation
          ("Senesco"),  Nava Leisure USA, Inc., an Idaho  corporation  ("Nava"),
          Nava  Leisure   Acquisition   Corp.,  a  New  Jersey  corporation  and
          wholly-owned   subsidiary   of  Nava   ("NAC"),   and  the   Principal
          Stockholders (as defined therein),  entered into an Agreement and Plan
          of Merger,  providing for the merger of NAC with and into Senesco, and
          the issuance to the  shareholders of Senesco one newly issued share of
          Common Stock of Nava for each share of Common Stock of Senesco whereby
          the  shareholders  of Senesco  acquired  a majority  of the issued and
          outstanding shares of Common Stock of Nava (the "Merger").  The Merger
          was  consummated  on  January  22,  1999,  the  date  upon  which  the
          Certificate  of Merger filed with the  Secretary of State of the State
          of New Jersey was declared  effective.  Upon the  consummation  of the
          Merger,   Senesco  was  the  surviving   corporation  and  remained  a
          subsidiary  of Nava which  changed  its name to Senesco  Technologies,
          Inc., an Idaho corporation ("STI").

          Umbrella was a shareholder of Senesco and  beneficially  owned 933,476
          shares of Common  Stock of  Senesco.  As a result  of the  Merger,  on
          January 22, 1999,  Umbrella received 933,476 shares of Common Stock of
          STI (formerly  Nava),  consisting of 34.57% of the 2,700,008 shares of
          STI Common Stock issued and outstanding.

          On  September  7,  1999,  STI  granted  to Mr.  Escaravage  options to
          purchase  40,000 shares of STI's Common  Stock,  on a post stock split
          adjusted  basis (as described  below),  at an exercise  price equal to
          $3.85 per share. Mr. Escaravage received such options as consideration
          for his services as a Director of STI. All such options are  currently
          vested.

          On September 29, 1999, STI declared a two-for-one  forward stock split
          of  its  issued  and  outstanding  Common  Stock  and,  as  a  result,
          Umbrella's holdings of STI Common Stock increased to 1,866,952 shares.

          On September 30, 1999,  STI merged with and into the Company,  for the
          sole  purpose of  reincorporating  the  corporation  from the State of
          Idaho to the State of Delaware.

 ITEM 4.  PURPOSE OF TRANSACTION.

          Mr.  Escaravage  is the founder of Senesco and a former  director  and
          executive  officer of the  Company.  The original  acquisition  of the
          shares of the  Company's  Common  Stock  reported  herein  was made to
          acquire a voting  interest  in the  Company  and an equity  investment
          interest in the Company in  connection  with the Merger on January 22,
          1999 (as described above).  Since January 22, 1999, Mr. Escaravage and
          Umbrella  have  disposed of shares of the  Company's  Common  Stock as
          outlined below.

                                Page 3 of 6 Pages


          On January 18,  2000,  Umbrella  sold 61,224  shares of the  Company's
          Common Stock to an unrelated  third party pursuant to a private resale
          agreement.

          Pursuant  to a Common  Stock  Purchase  Agreement  by and  between the
          Company and Umbrella, dated as of January 31, 2000, Umbrella purchased
          34,737  shares  of  the  Company's  restricted  Common  Stock  for  an
          aggregate purchase price of $100,000, using its working capital.

          On July 5, 2001,  Umbrella  transferred  by gift 40,000  shares of the
          Company's  Common  Stock  for no  consideration  to a trust  in  which
          neither Umbrella nor Mr. Escaravage claims beneficial ownership.  Also
          on July 5, 2001,  Umbrella sold 33,126 shares of the Company's  Common
          Stock pursuant to a private resale agreement and Umbrella  transferred
          166,250  shares of the  Company's  Common Stock as  consideration  for
          various business transactions.

          On July 31, 2001,  Umbrella sold 400,000 shares to an unrelated  third
          party pursuant to a private resale agreement.

          On October 1, 2001, Umbrella  transferred by gift 30,000 shares of the
          Company's Common Stock for no consideration to an individual.

          On December 1, 2001, Mr.  Escaravage  was granted  options to purchase
          40,000 shares of the Company's  Common Stock pursuant to the Company's
          1998 Stock Incentive  Plan, as amended,  at an exercise price of $2.26
          per share,  for his  services  performed as a director of the Company.
          One-half (1/2) of such options vested on December 1, 2001 and one-half
          (1/2) of such options will vest on December 1, 2002.

          On December 5, 2001,  Umbrella  sold 400,000  shares of the  Company's
          Common Stock to an unrelated  third party pursuant to a private resale
          agreement.

          Umbrella and/or Mr.  Escaravage may from time to time,  depending upon
          market  conditions,  the state of  affairs  of the  Company  and other
          factors,  acquire  additional  shares of Common  Stock of the Company,
          subject to applicable laws and to the availability of shares at prices
          deemed  favorable.  Alternatively,  Umbrella and/or Mr. Escaravage may
          dispose of shares of the Company's  Common Stock.  Umbrella and/or Mr.
          Escaravage will continue to consider their respective equity interests
          in the Company and they reserve the right to  formulate  such plans or
          proposals,  and to take such action,  as may seem appropriate in light
          of future circumstances.

          Except as set forth above,  neither  Umbrella nor Mr.  Escaravage have
          any present plans or intentions which would result in or relate to any
          of the following:

          (a)  The  acquisition  by any person of  additional  securities of the
               Company, or the disposition of securities of the Company;

          (b)  An  extraordinary  corporate  transaction,   such  as  a  merger,
               reorganization or liquidation, involving the Company;

          (c)  A sale or transfer of a material amount of assets of the Company;

          (d)  Any change in the present board of directors or management of the
               Company, including any plans or proposals to change the number or
               terms of  directors  or to fill  any  existing  vacancies  on the
               board;

          (e)  Any  material  change in the present  capitalization  or dividend
               policy of the Company;

          (f)  Any other material change in the Company's  business or corporate
               structure;

          (g)  Changes  in  the  Company's   charter,   bylaws  or   instruments
               corresponding  thereto  or other  actions  which may  impede  the
               acquisition of control of the Company by any person;

          (h)  Causing a class of  securities of the Company to be delisted from
               a national securities exchange or to cease to be authorized to be
               quoted  in  an  inter-dealer  quotation  system  of a  registered
               national securities association;

          (i)  A class of equity securities of the Company becoming eligible for
               termination of registration  pursuant to Section  12(g)(4) of the
               Act; or

                                Page 4 of 6 Pages


          (j)  Any action similar to any of those enumerated above.

 ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.

          (a)  Umbrella  is the  beneficial  owner and record  holder of 771,089
               shares of the  Company's  Common  Stock.  Umbrella  disclaims any
               beneficial  interest  in the  options to  purchase  shares of the
               Company's Common Stock held by Mr. Escaravage. Umbrella's 771,089
               shares  of  Common  Stock  represents  7.72%  of the  issued  and
               outstanding  shares  of  Common  Stock of the  Company,  based on
               9,987,187  shares issued and outstanding as of December 31, 2001.
               Mr.  Escaravage  is the  beneficial  owner of options to purchase
               60,000 shares of the Company's  Common Stock that are exercisable
               within 60 days.  The  options to  purchase  60,000  shares of the
               Company's common stock held by Mr. Escaravage represent less than
               1% of the issued and  outstanding  shares of Common  Stock of the
               Company,  based on 9,987,187  shares issued and outstanding as of
               December 31, 2001.

          (b)  Umbrella has the sole power to vote and the sole power to dispose
               of 771,089  shares of the  Company's  Common Stock held solely by
               it. Mr.  Escaravage has the sole power to vote and the sole power
               to  dispose  of and  options  to  purchase  60,000  shares of the
               Company's Common Stock held solely by him.

          (c)  During 2001, the percentage of the issued and outstanding  Common
               Stock  of  the  Company   beneficially   owned  by  Umbrella  was
               materially  reduced  due to (i) its gift and  transfer  of 40,000
               shares of the Company's  Common Stock in July 2001, (ii) its sale
               and transfer of 599,376  shares of the Company's  Common Stock to
               unrelated third parties in July 2001, (iii) its gift and transfer
               of 30,000 shares of the  Company's  Common Stock in October 2001,
               (iv) its sale and  transfer  of 400,000  shares of the  Company's
               Common Stock to an unrelated  third party in December  2001,  and
               (v) the  Company's  private  placements  of 1,142,858 and 665,714
               shares of restricted Common Stock in December 2001.

          (d)  No other  person  is known to have the  right to  receive  or the
               power to direct the receipt of  dividends  from,  or the proceeds
               from the sale of, such securities.

          (e)  Not applicable.

 ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH THE
          ISSUER.

          There  is no  contract,  arrangement,  understanding  or  relationship
          (legal or otherwise)  between Umbrella and the Company with respect to
          any securities of the Company,  including but not limited to, transfer
          of voting of any of the  securities,  finder's fees,  joint  ventures,
          loan or option  arrangements,  puts or calls,  guarantees  of profits,
          division of profits or loss, or the giving or withholding of proxies.

 ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS.

          None.


                                Page 5 of 6 Pages



                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.


                       The Umbrella Project, L.L.C. (Stockholder)


February 13, 2002      By: /s/ Phillip O. Escaravage
                          ------------------------------------------------------
                          Phillip O. Escaravage, Sole Member and Managing Member


          The original  statement shall be signed by each person on whose behalf
the  statement is filed or his  authorized  representative.  If the statement is
signed on behalf of a person by his  authorized  representative  (other  than an
executive  officer or general  partner of the filing  person),  evidence  of the
representative's  authority to sign on behalf of such person shall be filed with
the  statement,  provided,  however,  that a power of attorney  for this purpose
which is already on file with the Commission may be  incorporated  by reference.
The name and any title of each person who signs the statement  shall be typed or
printed beneath his signature.

          Attention.  Intentional  misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001).






                                Page 6 of 6 Pages